Drug
Talampanel clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How studies write it
Studies that test it under each name
Name
Studies by the year they started
12 studies that test it; most in 2003 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 4
Teva Branded Pharmaceutical Products R&D, Inc. (8) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · National Institutes of Health Clinical Center (CC) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses talampanel is read from its arms, and is right about nine times in ten.
Testing it · 12
- Safety and Efficacy of Talampanel in Glioblastoma MultiformeCompletedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT00267592Written as Talampanel
- Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)TerminatedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT00982150Written as Talampanel
- Talampanel in Treating Patients With Recurrent High-Grade GliomaCompletedPhase 2National Institutes of Health Clinical Center (CC)NCT00064363Written as talampanel
- Talampanel for Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT00696332Written as Talampanel
- Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTerminatedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT00062504Written as Talampanel
- Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCompletedPhase 1/2Teva Branded Pharmaceutical Products R&D, Inc.NCT00036296Written as talampanel
- Multicenter Trial for Adults With Partial SeizuresCompletedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT00034814Written as Talampanel
- A Phase 1 Study to Investigate the Effects of Talampanel on the Heart RhythmCompletedPhase 1Teva Branded Pharmaceutical Products R&D, Inc.NCT00964730Written as Talampanel
- A Study to Investigate the Absorption, Metabolism and Excretion of TalampanelTerminatedPhase 1Teva Branded Pharmaceutical Products R&D, Inc.NCT00868361Written as Talampanel (non-radiolabeled), [14C] Talampanel
- Effect of Talampanel (an AMPA Receptor Blocker) on Brain ActivityCompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00057460Written as Talampanel
- Study of LY300164 for the Treatment of Parkinson's DiseaseCompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00004576Written as LY300164
- Talampanel to Treat Parkinson's DiseaseCompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00108667Written as Talampanel
Codes
What other systems call talampanel · ClinicalTrials.gg INT003769
- MeSH (NLM) C085266talampanelOne source NLM
- UNII (FDA) CVS43XG1L5TALAMPANELConfirmed FDA, NLM, Wikidata
- Wikidata Q7678869talampanelConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C38139TalampanelOne source FDA
- DrugBank DB04982One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C085266 | talampanel | One source NLM |
| UNII (FDA) | CVS43XG1L5 | TALAMPANEL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7678869 | talampanel | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C38139 | Talampanel | One source FDA |
| DrugBank | DB04982 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.